EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High‐Grade Serous Ovarian Carcinoma

Ryosuke Uekusa, Akira Yokoi iD, Mayu Ukai, Kosuke Yoshida, Kunanon Chattrairat, Takao Yasui, Yasuhide Inokuma, Masami Kitagawa, Eri Asano-Inami, Masato Yoshihara, Satoshi Tamauchi, Nobuhisa Yoshikawa und 6 weitere

Journal of Extracellular Vesicles · 2026-05 · 15 (5)

DOI: 10.1002/jev2.70308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 15.05.2026. Verfasst von Ryosuke Uekusa und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, DNA Copy Number Variations, Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Science and Technology Agency, Japan Society for the Promotion of Science KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs), including exosomes, circulate in body fluids and carry pathological genomic information. High‐grade serous ovarian carcinoma (HGSOC) is the most common subtype of ovarian cancer, characterized predominantly by copy number variations (CNVs). This study evaluated the clinical significance of EV‐DNA focusing on CNV profiles and exploring its potential as a companion biomarker for predicting therapeutic response and supporting diagnosis in HGSOC. Droplet digital polymerase chain reaction detected concordant CNVs between tumor DNA and EV‐DNA in ascites but not in serum. EV‐DNA showed higher concordance with the CNV status of tumor DNA than cell‐free DNA in ascites. The EV‐DNA amount in malignant ascites was significantly higher than that in ascites from benign ovarian tumors ( p < 0.05), and elevated EV‐DNA was observed even in cytology‐negative ovarian cancer, suggesting an increase early in disease development. Moreover, CNV profiles showed marked differences between responders and nonresponders to poly(ADP‐ribose) polymerase (PARP) inhibitors. An equation based on five genes ( ARID1A, NOTCH3, CSMD3, ELP4 , and BARD1 ) showed strong predictive performance for olaparib response (area under the curve = 0.91). Collectively, these findings indicate that the CNV status of EV‐DNA may serve as a non‐invasive companion biomarker for patient stratification and therapeutic monitoring in HGSOC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesDNA Copy Number VariationsOvarian NeoplasmsBiomarkers, TumorCystadenocarcinoma, SerousHumansFemaleMiddle Aged

Stichwörter der Autor:innen

EV‐DNAcopy number variationsexosomesextracellular vesicleshigh‐grade serous ovarian carcinoma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nagoya University Institute For Advanced Research, Nagoya, Japan.
  • Japan Science and Technology Agency (JST), Kawaguchi, Japan.
  • Department of Gynecologic Oncology, Hyogo Cancer Center, Akashi, Hyogo, Japan.
  • Department of Life Science and Technology, Institute of Science Tokyo, Yokohama, Japan.
  • Division of Applied Chemistry, Faculty of Engineering, Hokkaido University, Sapporo, Hokkaido, Japan.

ORCID-Profile: Akira Yokoi, Takahiro Ochiya, Anil K Sood

Förderung

  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science KAKENHI
  • Princess Takamatsu Cancer Research Fund
  • Daiichi Sankyo Foundation of Life Science
  • Uehara Memorial Foundation
  • Tokai Pathways to Global Excellence
  • Strategic Professional Development Program for Young Researchers

Zitieren

APA

Uekusa, R., Yokoi, A., Ukai, M., Yoshida, K., Chattrairat, K., Yasui, T., Inokuma, Y., Kitagawa, M., Asano-Inami, E., Yoshihara, M., Tamauchi, S., Yoshikawa, N., Niimi, K., Matsuzaki, J., Ochiya, T., Sood, A. K., Yamamoto, Y., & Kajiyama, H. (2026). DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High‐Grade Serous Ovarian Carcinoma. Journal of Extracellular Vesicles, 15(5). https://doi.org/10.1002/jev2.70308

Vancouver

Uekusa R, Yokoi A, Ukai M, Yoshida K, Chattrairat K, Yasui T, et al. DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High‐Grade Serous Ovarian Carcinoma. Journal of Extracellular Vesicles. 2026;15(5). doi:10.1002/jev2.70308

BibTeX
@article{Uekusa2026,
  author = {Uekusa, Ryosuke and Yokoi, Akira and Ukai, Mayu and Yoshida, Kosuke and Chattrairat, Kunanon and Yasui, Takao and Inokuma, Yasuhide and Kitagawa, Masami and Asano-Inami, Eri and Yoshihara, Masato and Tamauchi, Satoshi and Yoshikawa, Nobuhisa and Niimi, Kaoru and Matsuzaki, Juntaro and Ochiya, Takahiro and Sood, Anil K and Yamamoto, Yusuke and Kajiyama, Hiroaki},
  title = {DNA Copy Number Profiling in Extracellular Vesicles as Clinical Biomarkers of High‐Grade Serous Ovarian Carcinoma},
  journal = {Journal of Extracellular Vesicles},
  year = {2026},
  volume = {15},
  number = {5},
  doi = {10.1002/jev2.70308}
}
Kostenlos starten →